Skip to main content

Advertisement

Log in

Characterizing hand and wrist ultrasound pattern in primary Sjögren’s syndrome: a case-control study

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Introduction/objectives

To evaluate the clinical relevance of high-resolution hand and wrist ultrasound (US) findings and their possible associations with anti-citrullinated peptide antibodies in primary Sjögren’s syndrome (pSS).

Methods

Ninety-seven consecutive pSS patients (American-European Consensus Group, 2002) without meeting the American College of Rheumatology (ACR) criteria (1987) for rheumatoid arthritis (RA); 20 RA patients (ACR/European League Against Rheumatism (EULAR) criteria, 2010); and 80 healthy individuals with comparable age, gender, and ethnicity were enrolled in a case-control study. Disease activity was assessed by EULAR Sjögren’s Syndrome Disease Activity Index (ESSDAI). US was performed by one expert blinded to anti-CCP, anti-MCV, and IgM rheumatoid factor tested by ELISA.

Results

Frequencies of grade 3 synovitis (9.3 vs. 0%, p = 0.004), tenosynovitis (36.1 vs. 3.8%, p < 0.001), and erosions (27.8 vs. 7.5%, p = 0.001) on US were higher in pSS patients than in healthy controls. ESSDAI presented a moderate correlation with the synovitis number (p = 0.001) and tenosynovitis (p < 0.001). Most pSS patients with erosions on US (81.5%) had negative anti-CCP. Nevertheless, anti-CCP ≥ 3× cut-off value was associated with the presence of erosions in pSS (p = 0.026). Erosions in pSS were mainly small size contrasting with moderate/large size in RA (p < 0.001), and positive power Doppler synovitis predominated in RA (p < 0.001).

Conclusions

US identified significant frequencies of grade 3 synovitis, tenosynovitis, and erosions in pSS. Synovitis and tenosynovitis numbers were correlated with ESSDAI. Association between erosions on US and anti-CCP (high titers) in pSS possibly identifies a subgroup with severe arthritis. These findings suggest that US is a useful method for assessing joint involvement in pSS.

Key Points

US identified significant frequencies of grade 3 synovitis, tenosynovitis, and erosions in pSS patients in comparison with age- and race-healthy individuals.

Numbers of synovitis and tenosynovitis on US were correlated with ESSDAI values.

Most pSS patients with erosions on US were negative for anti-CCP, but anti-CCP ≥ 3× cut-off value was associated with the presence of erosions in this disease.

Erosions in pSS were mainly small size contrasting with moderate/large size in RA, and positive power Doppler synovitis predominated in RA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Mariette X, Criswell LA (2018) Primary Sjögren’s syndrome. N Engl J Med 378:931–939

    PubMed  Google Scholar 

  2. Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, Zhong R (2015) Epidemiology of primary Sjögren’s syndrome: a systematic review and meta-analysis. Ann Rheum Dis 74:1983–1989

    CAS  PubMed  Google Scholar 

  3. Fauchais AL, Ouattara B, Gondran G, Lalloué F, Petit D, Ly K, Lambert M, Launay D, Loustaud-Ratti V, Bezanahari H, Liozon E, Hachulla E, Jauberteau MO, Vidal E, Hatron PY (2010) Articular manifestations in primary Sjögren’s syndrome: clinical significance and prognosis of 188 patients. Rheumatology 49:1164–1172

    PubMed  Google Scholar 

  4. Kamali S, Polat NG, Gul EKA, Ocal L, Aral O, Badur MKS et al (2005) Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sjögren’s syndrome and Wegener’s granulomatosis. Clin Rheumatol 24:673–676

    PubMed  Google Scholar 

  5. Alani H, Henty JR, Thompson NL, Jury E, Ciurtin C (2018) Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjögren’s syndrome (secondary Sjögren’s syndrome) focusing on autoimmune rheumatic diseases. Scand J Rheumatol 47:141–154

    CAS  PubMed  Google Scholar 

  6. Mathsson Alm L, Fountain DL, Cadwell KK, Madrigal AM, Gallo G, Poorafshar M (2018) The performance of anti-cyclic citrullinated peptide assays in diagnosing rheumatoid arthritis: a systematic review and meta-analysis. Clin Exp Rheumatol 36:144–152

    PubMed  Google Scholar 

  7. Harich R, Roger C, Garnier L, Bienvenu J, Fabien N (2014) Comparison of anti-CCP autoantibodies measurement by ELISA and a bead-based assay in a large patient cohort. Clin Biochem 47:485–488

    CAS  PubMed  Google Scholar 

  8. Gottenberg JE, Mignot S, Nicaise-Rolland P, Cohen-Solal J, Aucouturier F, Goetz J, Labarre C, Meyer O, Sibilia J, Mariette X (2005) Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren’s syndrome. Ann Rheum Dis 64:114–117

    CAS  PubMed  Google Scholar 

  9. Goëb V, Salle V, Duhaut P, Jouen F, Smail A, Ducroix JP et al (2007) Clinical significance of autoantibodies recognizing Sjögren’s syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome. Clin Exp Immunol 148:281–287

    PubMed  PubMed Central  Google Scholar 

  10. Atzeni F, Sarzi-Puttini P, Lama N, Bonacci E, Bobbio-Pallavicini F, Montecucco C et al (2008) Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis. Arthritis Res Ther 10:R51

    PubMed  PubMed Central  Google Scholar 

  11. Poulsom H, Charles PJ (2008) Antibodies to citrullinated vimentin are a specific and sensitive marker for the diagnosis of rheumatoid arthritis. Clin Rev Allergy Immunol 34:4–10

    CAS  PubMed  Google Scholar 

  12. Barcelos F, Abreu I, Patto JV, Trindade H, Teixeira A (2009) Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in Sjögren’s syndrome. Acta Rheumatol Port 34:608–612

    Google Scholar 

  13. Haga HJ, Andersen DT, Peen E (2011) Prevalence of IgA class antibodies to cyclic citrullinated peptide (anti-CCP) in patients with primary Sjögren's syndrome, and its association to clinical manifestations. Clin Rheumatol 30:369–372

    PubMed  Google Scholar 

  14. Kim SM, Park E, Lee JH, Lee SH, Kim HR (2012) The clinical significance of anti-cyclic citrullinated peptide antibody in primary Sjögren’s syndrome. Rheumatol Int 32:3963–3967

    CAS  PubMed  Google Scholar 

  15. Ryu YS, Park SH, Lee J (2013) Follow-up of primary Sjogren’s syndrome patients presenting positive anti-cyclic citrullinated peptides antibody. Rheumatol Int 33:1443–1446

    PubMed  Google Scholar 

  16. ter Borg EJ, Kelder JC (2016) Polyarthritis in primary Sjögren’s syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up. Clin Rheumatol 35:649–655

    PubMed  Google Scholar 

  17. Wakefield RJ, Gibbon WW, Conaghan PG, O'Connor P, Mc Gonagle D, Pease C et al (2000) The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography. Arthritis Rheum 43:2762–2770

    CAS  PubMed  Google Scholar 

  18. Riente L, Scirè CA, Delle Sedie A, Baldini C, Filippucci E, Meenagh G et al (2009) Ultrasound imaging for the rheumatologist. XXIII. Sonographic evaluation of hand joint involvement in primary Sjögren's syndrome. Clin Exp Rheumatol 27:747–750

    CAS  PubMed  Google Scholar 

  19. Iagnocco A, Modesti M, Priori R, Alessandri C, Perella C, Takanen S, Valesini G (2010) Subclinical synovitis in primary Sjögren’s syndrome: an ultrasonographic study. Rheumatology 49:1153–1157

    PubMed  Google Scholar 

  20. Amezcua-Guerra LM, Hofmann F, Vargas A, Rodriguez-Henriquez P, Solano C, Hernández-Díaz C et al (2013) Joint involvement in primary Sjögren’s syndrome: an ultrasound “target area approach to arthritis”. Biomed Res Int 2013:640265

    PubMed  PubMed Central  Google Scholar 

  21. Fujimura T, Fujimoto T, Hara R, Shimmyo N, Kobata Y, Kido A et al (2015) Subclinical articular involvement in primary Sjögren’s syndrome assessed by ultrasonography and its negative association with anti-centromere antibody. Mod Rheumatol 25:871–875

    CAS  PubMed  Google Scholar 

  22. Zayat AS, Ellegaard K, Conaghan PG, Terslev L, Hensor EM, Freeston JE, Emery P, Wakefield RJ (2015) The specificity of ultrasound-detected bone erosions for rheumatoid arthritis. Ann Rheum Dis 74:897–903

    PubMed  Google Scholar 

  23. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sjögren’s Syndrome (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324

    CAS  PubMed  Google Scholar 

  25. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580–1588

    PubMed  Google Scholar 

  26. Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, Gottenberg JE, Bootsma H, Mariette X, Vitali C, EULAR Sjögren’s Task Force (2010) EULAR Sjogren’s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren’s syndrome. Ann Rheum Dis 69:1103–1109

    PubMed  Google Scholar 

  27. Anderson JK, Zimmerman L, Caplan L, Michaud K (2011) Measures of rheumatoid arthritis disease activity: Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score with 28-Joint Counts (DAS28), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), Patient Activity Score (PAS) and Patient Activity Score-II (PASII), Routine Assessment of Patient Index Data (RAPID), Rheumatoid Arthritis Disease Activity Index (RADAI) and Rheumatoid Arthritis Disease Activity Index-5 (RADAI-5), Chronic Arthritis Systemic Index (CASI), Patient-Based Disease Activity Score With ESR (PDAS1) and Patient-Based Disease Activity Score without ESR (PDAS2), and Mean Overall Index for Rheumatoid Arthritis (MOI-RA). Arthritis Care Res 63(Suppl 11):S14–S36

    Google Scholar 

  28. Shidara K, Inoue E, Tanaka E, Hoshi D, Seto Y, Nakajima A, Momohara S, Taniguchi A, Yamanaka H (2011) Comparison of the second and third generation anti-cyclic citrullinated peptide antibody assays in the diagnosis of Japanese patients with rheumatoid arthritis. Rheumatol Int 31:617–622

    CAS  PubMed  Google Scholar 

  29. Backhaus M, Burmester GR, Gerber T, Grassi W, Machold KP, Swen WA, Wakefield RJ, Manger B, Working Group for Musculoskeletal Ultrasound in the EULAR Standing Committee on International Clinical Studies including Therapeutic Trials (2001) Working Group for Musculoskeletal Ultrasound in the EULAR Standing Committee on International Clinical Studies including Therapeutic Trials Guidelines for musculoskeletal ultrasound in rheumatology. Ann Rheum Dis 60:641–649

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Wakefield RJ, Balint PV, Szkudlarek M, Filippucci E, Backhaus M, D'Agostino MA, Sanchez EN, Iagnocco A, Schmidt WA, Bruyn GA, Kane D, O'Connor PJ, Manger B, Joshua F, Koski J, Grassi W, Lassere MN, Swen N, Kainberger F, Klauser A, Ostergaard M, Brown AK, Machold KP, Conaghan PG, OMERACT 7 Special Interest Group (2005) OMERACT 7 special interest group. Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol 32:2485–2487

    PubMed  Google Scholar 

  31. Szkudlarek M, Court-Payen M, Jacobsen S, Klarlund M, Thomsen HS, Østergaard M (2003) Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis. Arthritis Rheum 48:955–962

    PubMed  Google Scholar 

  32. Vlad V, Berghea F, Iagnocco A, Micu M, Damjanov N, Skakic V, Prodanovic S, Radunovic G, Szkudlarek M, Nestorova R, Petranova T, Kakavouli J, Porta F, Perricone C, Ciechomska A, Moller I, Varzaru L, Peric P, Dejaco C, Bojinca M, Fodor D, Milicescu M, Naredo E (2014) Inter & intra-observer reliability of grading ultrasound videoclips with hand pathology in rheumatoid arthritis by using non-sophisticated internet tools (LUMINA study). Med Ultrason 16:32–36

    PubMed  Google Scholar 

  33. Berglin E, Dahlqvist SR (2013) Comparison of the 1987 ACR and 2010 ACR/EULAR classification criteria for rheumatoid arthritis in clinical practice: a prospective cohort study. Scand J Rheumatol 42:362–368

    CAS  PubMed  Google Scholar 

  34. Ramos-Casals M, Brito-Zerón P, Font J (2007) Lessons from diseases mimicking Sjögren’s syndrome. Clin Rev Allergy Immunol 32:275–283

    PubMed  Google Scholar 

  35. Mangnus L, van Steenbergen HW, Lindqvist E, Brouwer E, Reijnierse M, Huizinga et al (2015) Studies on ageing and the severity of radiographic joint damage in rheumatoid arthritis. Arthritis Res Ther 17: 222

  36. Mangnus L, van Steenbergen HW, Reijnierse M, van der Helm-van Mil AHM (2016) Magnetic resonance imaging-detected features of inflammation and erosions in symptom-free persons from the general population. Arthritis Rheum 68:2593–2602

    CAS  Google Scholar 

  37. Maldini C, Seror R, Fain O, Dhote R, Amoura Z, De Bandt M et al (2014) Epidemiology of primary Sjögren’s syndrome in a French multiracial/multiethnic area. Arthritis Care Res 66:454–463

    Google Scholar 

  38. Brito-Zerón P, Acar-Denizli N, Zeher M, Rasmussen A, Seror R, Theander E, Li X, Baldini C, Gottenberg JE, Danda D, Quartuccio L, Priori R, Hernandez-Molina G, Kruize AA, Valim V, Kvarnstrom M, Sene D, Gerli R, Praprotnik S, Isenberg D, Solans R, Rischmueller M, Kwok SK, Nordmark G, Suzuki Y, Giacomelli R, Devauchelle-Pensec V, Bombardieri M, Hofauer B, Bootsma H, Brun JG, Fraile G, Carsons SE, Gheita TA, Morel J, Vollenveider C, Atzeni F, Retamozo S, Horvath IF, Sivils K, Mandl T, Sandhya P, de Vita S, Sanchez-Guerrero J, van der Heijden E, Trevisani VFM, Wahren-Herlenius M, Mariette X, Ramos-Casals M, EULAR-SS Task Force Big Data Consortium (2017) Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren’s syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium. Ann Rheum Dis 76:1042–1050

    PubMed  Google Scholar 

  39. Brandt JE, Priori R, Valesini G, Fairweather D (2015) Sex differences in Sjögren’s syndrome: a comprehensive review of immune mechanisms. Biol Sex Differ 6:19

    PubMed  PubMed Central  Google Scholar 

  40. McBurney CA, Vina ER (2012) Racial and ethnic disparities in rheumatoid arthritis. Curr Rheumatol Rep 14:463–471

    PubMed  Google Scholar 

  41. Sweeney SE, Harris ED Jr, Firestein GS (2013) Clinical features of rheumatoid arthritis. In: Firestein GS, Budd RC, Gabriel SE, McInnes IB, O’Dell JR (eds) Kelley’s textbook of rheumatology, 9rd edn. Elsevier Saunders, Philadelphia, pp 1109–1136

    Google Scholar 

  42. Padovano I, Costantino F, Breban M, D'Agostino MA (2016) Prevalence of ultrasound synovial inflammatory findings in healthy subjects. Ann Rheum Dis 75:1819–1823

    PubMed  Google Scholar 

  43. Lei L, Morgan S, Ntatsaki E, Ciurtin C (2019) Comparative assessment of hand joint ultrasound findings in symptomatic patients with systemic lupus erythematosus and Sjögren’s syndrome: a pilot study. Ultrasound Med Biol 45:452–460

    PubMed  Google Scholar 

  44. Budhram A, Chu R, Rusta-Sallehy S, Ioannidis G, Denburg JA, Adachi JD, Haaland DA (2014) Anti-cyclic citrullinated peptide antibody as a marker of erosive arthritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Lupus 23:1156–1163

    CAS  PubMed  Google Scholar 

  45. Molano-González N, Olivares-Martínez E, Anaya JM, Hernández-Molina G (2019) Anti-citrullinated protein antibodies and arthritis in Sjögren’s syndrome: a systematic review and meta-analysis. Scand J Rheumatol 48:157–163

    PubMed  Google Scholar 

Download references

Funding

This study was supported by grants from the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) (#2010/10013-4) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPQ) (#305068/2014-8 to EB).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. G. Pasoto.

Ethics declarations

The project was approved by the local Ethics Committee (05204912.7.0000.0068), and all patients and healthy individuals signed the informed consent form.

Disclosures

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guedes, L.K.N., Leon, E.P., Bocate, T.S. et al. Characterizing hand and wrist ultrasound pattern in primary Sjögren’s syndrome: a case-control study. Clin Rheumatol 39, 1907–1918 (2020). https://doi.org/10.1007/s10067-020-04983-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-020-04983-y

Keywords

Navigation